Ecolab Inc. vs InMode Ltd — how do they compare? Ecolab Inc. trades at $281.36 (market cap $77.96B), while InMode Ltd trades at $14.07 (market cap $806.05M). The key difference: Ecolab Inc. is far larger — about 96.7× InMode Ltd's market cap, and Ecolab Inc. pays a 1.05% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecolab Inc. for 90 Days and InMode Ltd for 29 Days on average.
| ECL | INMD | |
|---|---|---|
Market Cap | $77.96B | $806.05M |
Volume | 1,145,536 | 511,446 |
Sector | Basic Materials | Health |
52-Week High | $308.35 | $16.62 |
52-Week Low | $245.73 | $12.76 |
Typical Hold Time | 90 Days | 29 Days |
Enterprise Value | $86.74B | $309.39M |
Dividend Yield | 1.05% | — |
Signals from Pluang's Aura AI — not financial advice
Ecolab (ECL) trades at $281.69, up 0.31% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $326.38. The company reported revenue of $16.08B in 2025 with a net income margin of 12.57%, and recent earnings have mostly met or exceeded expectations. Strong institutional buying and insider purchases, alongside positive news coverage highlighting its dividend growth and essential business model, support a constructive outlook.
The stock presents a favorable risk-reward profile given its steady revenue growth, high profitability, and analyst optimism, though elevated valuation ratios and increased debt from the CoolIT acquisition pose risks. The upcoming Q3 2026 earnings report on October 27, 2026, will be a key catalyst for near-term price direction.
INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.
The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.
Trailing returns across standard periods
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →